A084 Similar Benefit in Patients Aged q 75 Years Versus < 75 Years with VMP in First-Line MM and Bortezomib in Relapsed MM — Martin Kropff (2009) | RDL Network
Meletios A Dimopoulos, Robert Z. Orlowski, Thierry Façon, Pieter Sonneveld, Kenneth C. Anderson, Meral Beksaç, Lotfi Benboubker, Huw Roddie, Anna Potamianou, Catherine Couturier, Huaibao Feng, Ö. Ataman, Helgi van de Velde, Paul G. Richardson
PG Richardson, Rudolf Schlag, Nuriet K. Khuageva, Meletios A Dimopoulos, Ofer Shpilberg, Martin Kropff, Michel Delforge, MT Petrucci, Viktor Rossiev, Jian Hou, Tadeusz Robak, MV Mateos, KC Anderson, Andrew Cakana, Anita P. Liu, William Deraedt, Helgi van de Velde, Jesús F. San Miguel
M Delforge, M.J. Kropff, Ivan Špička, M. Petrucci, PG Richardson, Rudolf Schlag, N Khuageva, Meletios A Dimopoulos, Ofer Shpilberg, Olga Samoilova, MV Mateos, K Liu, William Deraedt, Helgi van de Velde, Jesús F. San Miguel
Annabelle Santos Volgman, Gatha Nair, Radmila Lyubarova, Faisal M. Merchant, Pamela Mason, Anne B. Curtis, Nanette K. Wenger, Neelum T. Aggarwal, James N. Kirkpatrick, Emelia Benjamin
Discussion(0)
No comments yet. Be the first to comment.